行情

ONTX

ONTX

Onconova医疗
NASDAQ

实时行情|Nasdaq Last Sale

0.3501
+0.0501
+16.70%
盘后: 0.3569 +0.0068 +1.94% 16:51 11/15 EST
开盘
0.3150
昨收
0.3000
最高
0.3800
最低
0.3000
成交量
24.90万
成交额
--
52周最高
4.826
52周最低
0.2975
市值
286.99万
市盈率(TTM)
-0.0964
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ONTX 新闻

  • 分析师:某位投资大佬可能正在“嗅探”Netflix
  • 新浪财经.1小时前
  • FAA局长:737 MAX机型获复飞批准"不受时间表指引"
  • 新浪美股.1小时前
  • ExodusPoint对冲基金将重新开放 拟募集超过20亿美元
  • 新浪美股.2小时前
  • 愿景基金二期已筹集20亿美元 但尚不及目标资金零头
  • 新浪美股.2小时前

更多

所属板块

制药
+1.25%
制药与医学研究
+1.32%

热门股票

名称
价格
涨跌幅

ONTX 简况

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.
展开

Webull提供Onconova Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。